BioSpace News Archive

West Pharmaceutical Services, Inc. announced that the Company’s Board of Directors has approved a first-quarter 2020 dividend of $0.16 per share.

Puma Biotechnology, Inc., a biopharmaceutical company, will present updated interim results from a Phase II clinical trial of Puma’s drug neratinib at the 2019 San Antonio Breast Cancer Symposium that is currently taking place in San Antonio, Texas.

Anixa Biosciences, Inc. announced that it will hold a conference call on December 17, 2019 at 1:30 p.m. Pacific / 4:30 p.m. Eastern to discuss the progress made and the future plans for its CchekTM artificial intelligence based cancer diagnostic test and its CAR-T based ovarian cancer therapeutic and breast cancer vaccine programs.

Susan G. Komen®, the world’s leading breast cancer organization, welcomed the results of the INFORM trial that were announced at the 2019 San Antonio Breast Cancer Symposium.

The Institute for Functional Medicine (IFM) today announced that Joseph E. Pizzorno, ND, has been elected Chairman of its governing Board of Directors

The board of directors of Abbott (NYSE: ABT) today increased the company’s quarterly common dividend to 36 cents per share – a 12.5% increase.

A breathalyzer measures the amount of alcohol in the air a user breathes out.

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced an exceptional year in research, including the first published studies using samples from the Lyme Disease Biobank and advances in research of disulfiram for treating individuals suffering from chronic Lyme disease and chronic babesiosis, an approach that BAL was the first to support.

Technavio has announced its latest market research report titled global urethral dilator market 2019-2023

Defeat Diabetes Foundation travels to Cambodia to speak with local fishermen about the declining fish population and its effect on their health